Oxcarbazepine Tablet, Film Coated
Product Images NDC 87063-208

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 87063-208). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

300 (Label 300mg)

Packaging labels for Oxcarbazepine Tablets USP 300 mg by Enovachem Pharmaceuticals, showing various package sizes (30, 60, 90, 100 tablets). Each label includes the NDC number (87063-208-xx), manufacturer and source details, dosage form as film-coated tablets for oral use, and storage instructions. Batch, lot, and expiration fields are present but not filled in.*

FDA Label Image

Oxcarbazepinfig1 (Oxcarbazepinfig1)

A Kaplan-Meier curve chart showing exit rates over time from Day 2 to Day 11 for two treatment groups: Oxcarbazepine and Placebo. The x-axis represents time on trial in days, and the y-axis shows the exit rate. The chart includes a log-rank test p-value of 0.0001, indicating statistical comparison between the two groups.*

FDA Label Image

Oxcarbazepinfig2 (Oxcarbazepinfig2)

A Kaplan-Meier curve chart depicting seizure rate over days from first dose to first seizure for two treatment groups: Oxcarbazepine (solid line) and Placebo (dashed line). The y-axis represents seizure rate from 0.0 to 1.0, and the x-axis shows days from 0 to approximately 140. A log-rank test p-value of 0.046 is noted.*

FDA Label Image

Oxcarbazepinfig3 (Oxcarbazepinfig3)

A Kaplan-Meier plot showing exit rate over time in days for two treatment groups labeled 'High' and 'Low.' The y-axis represents the exit rate from 0.0 to 1.0, and the x-axis represents time to exit in days from 0 to 140. The 'Low' treatment group shows a steeper increase in exit rate compared to the 'High' group.*

FDA Label Image

Oxcarbazepinfig4 (Oxcarbazepinfig4)

A Kaplan-Meier survival curve graph depicting exit rate over time to exit in days. The chart compares two treatment groups labeled 'High' and 'Low', with exit rates on the vertical axis and time to exit in days on the horizontal axis. A log-rank test p-value of 0.0001 is shown, indicating a statistical comparison between the groups.*

FDA Label Image

Oxcarbazepinstructure (Oxcarbazepinstructure)

Chemical structure of oxcarbazepine, showing its molecular framework with two benzene rings fused to a seven-membered ring containing nitrogen, and functional groups including a ketone and an amide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.